EVMN
Evommune, Inc.
Company overview
- Market capitalization
- $304.49M
- Employees
- 48
- Latest publication
- 2026-09-29
About Evommune, Inc.
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 10,000,000USD | — | 3,000,000USD | 0USD | 0USD | — |
| Cost Of Revenue | 349,000USD | 326,000USD | 311,000USD | 375,000USD | 377,000USD | — | — | 325,000USD |
| Gross Profit | -349,000USD | -326,000USD | 10,000,000USD | -375,000USD | 2,623,000USD | — | — | -325,000USD |
| Research Development | 17,319,000USD | 20,403,000USD | 19,639,000USD | 19,638,000USD | 14,362,000USD | 15,559,500USD | 13,289,000USD | 25,178,000USD |
| Selling General Administrative | 6,635,000USD | 7,173,000USD | 3,689,000USD | 3,356,000USD | — | 2,390,000USD | 3,228,000USD | — |
| Total Operating Expenses | 23,605,000USD | 29,716,000USD | 23,328,000USD | 22,619,000USD | 17,655,000USD | 18,985,000USD | 16,517,000USD | 27,964,000USD |
| Operating Income | -23,954,000USD | -29,716,000USD | -13,328,000USD | -22,994,000USD | -15,032,000USD | -18,985,000USD | -16,517,000USD | -28,289,000USD |
| Interest Income | 2,284,000USD | 1,443,000USD | 862,000USD | — | — | 727,000USD | 618,000USD | — |
| Net Interest Income | 2,284,000USD | 1,443,000USD | 862,000USD | — | — | 727,000USD | 618,000USD | — |
| Income Before Tax | -21,674,000USD | -28,273,000USD | -12,475,000USD | -13,565,000USD | -14,557,000USD | -18,321,000USD | -15,916,000USD | -27,382,000USD |
| Net Income | -21,674,000USD | -28,273,000USD | -12,475,000USD | -13,565,000USD | -14,557,000USD | -18,321,000USD | -15,916,000USD | -27,382,000USD |
| Net Income From Continuing Ops | -21,674,000USD | -28,273,000USD | -12,475,000USD | — | — | -20,726,000USD | -15,916,000USD | — |
| Ebit | -21,674,000USD | -28,273,000USD | -12,475,000USD | -13,562,000USD | -14,553,000USD | -18,321,000USD | — | -27,373,000USD |
| Ebitda | -21,325,000USD | -27,947,000USD | -12,164,000USD | -13,187,000USD | -14,176,000USD | -17,975,500USD | — | -27,048,000USD |
| Depreciation And Amortization | 349,000USD | 326,000USD | 311,000USD | 375,000USD | 377,000USD | 345,500USD | — | 325,000USD |
| Reconciled Depreciation | 349,000USD | 326,000USD | 311,000USD | — | — | 360,000USD | 331,000USD | — |
| Total Other Income Expense Net | 2,280,000USD | 1,443,000USD | 853,000USD | 9,429,000USD | 475,000USD | 664,000USD | -17,000USD | 907,000USD |
| Selling And Marketing Expenses | — | 2,140,000USD | — | — | — | 1,035,500USD | — | — |
| Interest Expense | — | — | — | 3,000USD | 4,000USD | — | — | 9,000USD |
| Unclassified Operating Expenses | — | — | — | — | 3,293,000USD | — | — | 2,786,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|
| Total Revenue | 13,000,000USD | 5,000,000USD |
| Cost Of Revenue | 1,389,000USD | 1,000,000USD |
| Gross Profit | 13,000,000USD | 4,000,000USD |
| Research Development | 74,042,000USD | 31,997,000USD |
| Selling General Administrative | 20,029,000USD | — |
| Total Operating Expenses | 94,071,000USD | 41,850,000USD |
| Operating Income | -81,071,000USD | -37,850,000USD |
| Interest Income | 3,323,000USD | — |
| Interest Expense | 7,000USD | 58,000USD |
| Net Interest Income | 3,323,000USD | — |
| Income Before Tax | -68,870,000USD | -34,053,000USD |
| Net Income | -68,870,000USD | -34,053,000USD |
| Net Income From Continuing Ops | -68,870,000USD | — |
| Ebit | -68,870,000USD | -33,995,000USD |
| Ebitda | -67,481,000USD | -32,995,000USD |
| Depreciation And Amortization | 1,389,000USD | 1,000,000USD |
| Reconciled Depreciation | 1,389,000USD | — |
| Total Other Income Expense Net | 12,201,000USD | 3,797,000USD |
| Unclassified Operating Expenses | — | 9,853,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 322,455,000USD | 224,946,000USD | 84,544,000USD | 96,210,000USD | 56,016,000USD | 76,055,000USD | — | — |
| Intangible Assets | 1,385,879USD | — | — | — | — | — | — | — |
| Other Current Assets | 4,391,000USD | 4,278,000USD | 4,779,000USD | 8,100,000USD | 5,912,000USD | 3,896,000USD | — | — |
| Total Liab | 17,900,000USD | 19,380,000USD | 267,680,999USD | 267,442,999USD | 214,254,000USD | 220,292,000USD | — | — |
| Total Stockholder Equity | 304,555,000USD | 205,566,000USD | -183,137,000USD | -171,233,000USD | -158,238,000USD | 47,539,000USD | — | — |
| Other Current Liab | 4,741,000USD | 9,564,000USD | 6,336,000USD | 5,954,000USD | 13,721,000USD | 17,840,000USD | — | — |
| Common Stock | 4,000USD | 3,000USD | — | — | 1,000USD | 1,000USD | — | — |
| Capital Stock | 4,000USD | 3,000USD | 0USD | — | — | 0USD | — | — |
| Retained Earnings | -242,763,000USD | -221,089,000USD | -192,816,000USD | -180,341,000USD | -166,776,000USD | -152,219,000USD | — | — |
| Good Will | 818,139USD | — | — | — | — | — | — | — |
| Cash | 48,318,000USD | 44,063,000USD | 26,818,000USD | 61,837,000USD | 5,704,000USD | 16,254,999USD | — | — |
| Cash And Short Term Investments | 211,464,000USD | 149,200,000USD | 76,062,000USD | 86,795,000USD | 48,414,000USD | 72,040,000USD | — | — |
| Total Current Assets | 215,855,000USD | 153,478,000USD | 80,841,000USD | 94,895,000USD | 54,326,000USD | 73,988,000USD | — | — |
| Total Current Liabilities | 10,603,000USD | 17,909,000USD | 10,416,000USD | 10,092,000USD | 22,039,000USD | 27,981,000USD | — | — |
| Net Debt | -39,204,000USD | -42,003,000USD | 230,951,000USD | 195,979,000USD | 187,250,000USD | -14,876,999USD | — | — |
| Short Term Debt | 1,817,000USD | 589,000USD | 504,000USD | 465,000USD | 745,000USD | 1,877,000USD | — | — |
| Short Long Term Debt Total | 9,114,000USD | 2,060,000USD | 257,769,000USD | 257,816,000USD | 192,954,000USD | 1,378,000USD | — | — |
| Long Term Investments | 95,548,000USD | 67,489,000USD | — | — | — | 0USD | — | — |
| Short Term Investments | 163,146,000USD | 105,137,000USD | 49,244,000USD | 24,958,000USD | 42,710,000USD | 55,785,000USD | — | — |
| Accounts Payable | 4,045,000USD | 7,756,000USD | 3,576,000USD | 3,673,000USD | 7,573,000USD | 8,263,999USD | — | — |
| Property Plant Equipment Net | 9,570,000USD | 2,463,000USD | 1,130,000USD | 1,046,000USD | 1,421,000USD | 1,798,000USD | — | — |
| Property Plant Equipment Gross | 9,570,000USD | 4,022,000USD | 1,130,000USD | — | — | 1,798,000USD | — | — |
| Common Stock Shares Outstanding | 33,670,148shares | 31,524,093shares | 31,524,093shares | 30,077,560shares | 30,077,560shares | 30,077,560shares | 30,077,560shares | 30,077,560shares |
| Non Current Assets Total | 106,600,000USD | 71,467,999USD | 3,703,000USD | 1,314,999USD | 1,689,999USD | 2,067,000USD | — | — |
| Non Current Liabilities Total | 7,296,999USD | 1,471,000USD | 257,265,000USD | 257,351,000USD | 192,214,999USD | 192,311,000USD | — | — |
| Non Currrent Assets Other | -2,131,018USD | 100,999USD | 1,161,000USD | 60,999USD | 60,999USD | 61,000USD | — | — |
| Net Working Capital | 205,252,000USD | 135,569,000USD | 71,525,000USD | — | — | 46,007,000USD | — | — |
| Unclassified Non Current Liabilities | 7,296,999USD | 1,471,000USD | 257,004,000USD | 257,351,000USD | 192,214,999USD | 191,776,000USD | — | — |
| Unclassified Equity | 547,310,000USD | 426,649,000USD | 9,679,000USD | 9,108,000USD | 8,537,000USD | 199,757,000USD | — | — |
| Unclassified Non Current Assets | — | 1,415,000USD | 1,412,000USD | — | — | — | — | — |
| Non Current Liabilities Other | — | — | 261,000USD | — | — | 535,000USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | -1,947,999USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Total Assets | 224,946,000USD | 76,055,000USD | 82,249,000USD |
| Other Current Assets | 4,278,000USD | 1,948,000USD | 948,000USD |
| Total Liab | 19,380,000USD | 220,292,000USD | 159,963,000USD |
| Total Stockholder Equity | 205,566,000USD | -144,237,000USD | -77,714,000USD |
| Other Current Liab | 9,564,000USD | 15,699,000USD | 4,330,000USD |
| Common Stock | 3,000USD | 1,000USD | 1,000USD |
| Capital Stock | 3,000USD | — | — |
| Retained Earnings | -221,089,000USD | -152,219,000USD | -83,911,000USD |
| Cash | 44,063,000USD | 16,254,999USD | 29,024,000USD |
| Cash And Short Term Investments | 149,200,000USD | 72,040,000USD | 79,084,000USD |
| Total Current Assets | 153,478,000USD | 73,988,000USD | 80,032,000USD |
| Total Current Liabilities | 17,909,000USD | 27,981,000USD | 6,857,000USD |
| Net Debt | -42,003,000USD | 177,058,000USD | 121,606,000USD |
| Short Term Debt | 589,000USD | 1,018,000USD | 769,000USD |
| Short Long Term Debt Total | 2,060,000USD | 193,313,000USD | 150,630,000USD |
| Long Term Investments | 67,489,000USD | 0USD | — |
| Short Term Investments | 105,137,000USD | 55,785,000USD | 50,060,000USD |
| Accounts Payable | 7,756,000USD | 8,263,999USD | 1,758,000USD |
| Property Plant Equipment Net | 2,463,000USD | 1,798,000USD | 1,965,000USD |
| Property Plant Equipment Gross | 4,022,000USD | 2,746,000USD | — |
| Common Stock Shares Outstanding | 31,524,093shares | 30,077,560shares | 30,077,560shares |
| Non Current Assets Total | 71,467,999USD | 2,067,000USD | 2,216,999USD |
| Non Current Liabilities Total | 1,471,000USD | 192,311,000USD | 153,106,000USD |
| Non Currrent Assets Other | 100,999USD | 61,000USD | 43,999USD |
| Net Working Capital | 135,569,000USD | — | — |
| Unclassified Non Current Assets | 1,415,000USD | — | — |
| Unclassified Non Current Liabilities | 1,471,000USD | 192,311,000USD | 153,106,000USD |
| Unclassified Equity | 426,649,000USD | 7,981,000USD | 6,196,000USD |
| Current Deferred Revenue | — | 3,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -21,674,000USD | -28,273,000USD | -12,475,000USD | -13,565,000USD | -14,557,000USD | -18,321,000USD | -15,916,000USD | -27,382,000USD |
| Depreciation | 349,000USD | 326,000USD | 311,000USD | 375,000USD | 377,000USD | 345,500USD | 331,000USD | 325,000USD |
| Stock Based Compensation | 3,454,000USD | 4,196,000USD | 560,000USD | — | — | 448,000USD | 402,000USD | — |
| Other Non Cash Items | 2,662,000USD | 3,611,000USD | 49,000USD | -8,745,000USD | 244,000USD | -5,150,000USD | -325,000USD | -62,000USD |
| Change In Working Capital | -8,840,000USD | 7,637,000USD | 2,480,000USD | -4,273,000USD | -9,963,000USD | 308,000USD | -10,719,000USD | 18,493,000USD |
| Total Cash From Operating Activities | -27,503,000USD | -16,699,000USD | -9,635,000USD | -26,208,000USD | -23,899,000USD | -22,369,500USD | -26,227,000USD | -8,626,000USD |
| Capital Expenditures | -83,000USD | -104,000USD | -131,000USD | 0USD | 0USD | 0USD | 0USD | -18,000USD |
| Free Cash Flow | -27,586,000USD | -16,803,000USD | -9,766,000USD | -26,208,000USD | -23,899,000USD | -22,369,500USD | -26,227,000USD | -8,644,000USD |
| Investments | -85,276,000USD | -122,797,000USD | -23,775,000USD | — | — | -33,080,000USD | 9,412,000USD | — |
| Total Cashflows From Investing Activities | -85,359,000USD | -122,901,000USD | -23,906,000USD | 18,000,000USD | 13,500,000USD | -11,834,000USD | — | 10,027,000USD |
| Net Borrowings | -87,000USD | -86,000USD | -95,000USD | — | — | -84,000USD | -59,000USD | — |
| Total Cash From Financing Activities | 117,111,000USD | 156,848,000USD | -274,000USD | 64,340,999USD | -152,000USD | 24,793,500USD | -114,000USD | -108,000USD |
| Issuance Of Capital Stock | 117,198,000USD | 0USD | 0USD | — | — | 49,829,000USD | 0USD | — |
| Change In Cash | 4,255,000USD | 17,245,000USD | -35,019,000USD | 56,133,000USD | 5,704,000USD | -1,891,000USD | -16,929,000USD | 1,293,000USD |
| Begin Period Cash Flow | 44,063,000USD | 26,818,000USD | 61,837,000USD | 5,704,000USD | 16,463,000USD | 18,354,000USD | 35,283,000USD | 33,990,000USD |
| End Period Cash Flow | 48,318,000USD | 44,063,000USD | 26,818,000USD | 61,837,000USD | 5,704,000USD | 16,463,000USD | 18,354,000USD | 35,283,000USD |
| Other Cashflows From Investing Activities | -85,276,000USD | — | — | — | — | -11,834,000USD | — | — |
| Unclassified Operating Cash Flow | -3,454,000USD | -4,196,000USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | 85,276,000USD | — | — | 18,000,000USD | 13,500,000USD | 33,080,000USD | — | 10,045,000USD |
| Other Cashflows From Financing Activities | — | -1,224,000USD | 1,045,000USD | -736,000USD | -154,000USD | 24,793,500USD | — | -108,000USD |
| Unclassified Financing Cash Flow | — | 158,158,000USD | -1,224,000USD | 65,076,999USD | — | -49,745,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Net Income | -68,870,000USD | -66,808,000USD | -34,053,000USD |
| Depreciation | 1,389,000USD | 1,287,000USD | 1,000,000USD |
| Stock Based Compensation | 5,856,000USD | — | — |
| Other Non Cash Items | -4,841,000USD | -98,000USD | -261,000USD |
| Change In Working Capital | -4,119,000USD | 7,424,000USD | 3,344,000USD |
| Total Cash From Operating Activities | -76,441,000USD | -58,195,000USD | -29,970,000USD |
| Capital Expenditures | -235,000USD | -88,000USD | -118,000USD |
| Free Cash Flow | -76,676,000USD | -58,283,000USD | -30,088,000USD |
| Investments | -115,072,000USD | — | — |
| Total Cashflows From Investing Activities | -115,307,000USD | -3,993,000USD | -48,433,000USD |
| Net Borrowings | -373,000USD | — | — |
| Total Cash From Financing Activities | 220,763,000USD | 49,419,000USD | 63,753,000USD |
| Issuance Of Capital Stock | 65,228,000USD | — | — |
| Change In Cash | 27,808,000USD | -12,769,000USD | 29,024,000USD |
| Begin Period Cash Flow | 16,254,999USD | 29,024,000USD | — |
| End Period Cash Flow | 44,063,000USD | 16,254,999USD | 29,024,000USD |
| Other Cashflows From Financing Activities | -1,224,000USD | -423,000USD | -230,000USD |
| Unclassified Operating Cash Flow | -5,856,000USD | — | — |
| Unclassified Financing Cash Flow | 157,132,000USD | 49,842,000USD | 63,983,000USD |
| Unclassified Investing Cash Flow | — | -3,905,000USD | -48,315,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.